Document Type : Clinical Notes


Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran




  1. Montoya JP, Pena A, Sobrino FE, et al. Central and peripheral nervous system involvement by COVID-19: A systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis 2021; 21(1): 515.
  2. Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol 2020; 267(10): 2799-802.
  3. Notarte KI, Senanayake S, Macaranas I, Albano PM, Mundo L, Fennell E, et al. MicroRNA and other non-coding RNAs in Epstein-Barr virus-associated cancers. Cancers (Basel) 2021; 13(15).
  4. Kennedy PGE, Mogensen TH. Varicella-Zoster virus infection of neurons derived from neural stem cells. Viruses 2021; 13(3).
  5. Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 2016; 13(4): 3391-6.
  6. Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 2022; 375(6578): 296-301.
  7. Mechelli R, Romano C, Reniè R, Manfrè G, Buscarinu MC, Romano S, et al. Viruses and neuroinflammation in multiple sclerosis. Neuroimmunol Neuroinflamm 2021; 8: 269.
  8. Friedman JE, Lyons MJ, Cu G, Ablashl DV, Whitman JE, Edgar M, et al. The association of the human herpesvirus-6 and MS. Mult Scler 1999; 5(5): 355-62.
  9. Talbot PJ, Boucher A, Duquette P, Gruslin E. Coronaviruses and Neuroantigens: myelin proteins, myelin genes. In: Lavi E, Constantinescu CS, editors. Experimental models of multiple sclerosis. Boston, MA: Springer US; 2005. p. 781-91.
  10. Petkovic F, Castellano B. The role of interleukin-6 in central nervous system demyelination. Neural Regen Res 2016; 11(12): 1922-3.
  11. Satheesh NJ, Salloum-Asfar S, Abdulla SA. The potential role of COVID-19 in the pathogenesis of multiple sclerosis-a preliminary report. Viruses 2021; 13(10).
  12. Karsidag S, Sahin S, Ates MF, Cinar N, Kendirli S. demyelinating disease of the central nervous system concurrent with COVID-19. Cureus 2021; 13(8): e17297.
  13. Yavari F, Raji S, Moradi F, Saeidi M. demyelinating changes alike to multiple sclerosis: A case report of rare manifestations of COVID-19. Case Rep Neurol Med 2020; 2020: 6682251.
  14. Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, et al. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020; 162(7): 1491-4.
  15. Sarwar S, Rogers S, Mohamed AS, Ogula E, Ayantayo RA, Ahmed A, et al. Multiple sclerosis following SARS-CoV-2 infection: A case report and literature review. Cureus 2021; 13(10): e19036.
  16. Naser Moghadasi A. A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis. Autoimmun Rev 2021; 20(5): 102803.
  17. Palao M, Fernandez-Diaz E, Gracia-Gil J, Romero-Sanchez CM, Diaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord 2020; 45: 102377.
  18. Ismail II, Al-Hashel J, Alroughani R, Ahmed SF. A case report of multiple sclerosis after COVID-19 infection: Causality or coincidence? Neuroimmunology Reports 2021; 1: 100008.
  19. Moore L, Ghannam M, Manousakis G. A first presentation of multiple sclerosis with concurrent COVID-19 infection. eNeurologicalSci 2021; 22: 100299.